ARCHIVES

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership

July 10, 1992

UCLA, NYU Get Money, Near comprehensive Identification

May 30, 1975

Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress

October 31, 2003

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase

December 3, 2010